Search Filters

Search Results

Found 3 results

510(k) Data Aggregation

    K Number
    K110375
    Manufacturer
    Date Cleared
    2012-02-23

    (379 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    BLUESHINE SRL

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Blueshine GOLD series , (and the fiber delivery systems and accessories used to deliver laser energy), is indicated for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: gastroenterology, neurosurgery, general surgery, genitourinary surgery (urology), thoracic surgery, gynecology (GYN), pulmonology, ophthalmology, orthopedics, otolaryngology (ENT) and podiatry.

    The Blueshine GOLD series Laser is indicated for use in the performance of specific surgical applications in gastroenterology, neurosurgery, general surgery, genitourinary surgery (urology), thoracic surgery, gynecology {GYN), pulmonology, ophthalmology, orthopedics, otolaryngology (ENT) and podiatry as follows:

    Gastroenterology: The ablation, vaporization, excision, incision, and coagulation of soft ussue in gastroenterology procedures. Applications include: hemostasis of esophageal varices; palliation of malignant dysphagia; palliative ablation of obstructive neoplasms; hemostasis of colonoscopy.

    Neurosurgery: The ablation, vaporization, excision, incision, and coagulation of soft tissue in neurosurgery procedures. Applications include: tumors adjacent to the spinal cord; tumors adjacent to the cortex.

    General Surgery: Treatment of varicose veins and varicosities associated with superficial reflux of the greater saphenous vein. The ablation, vaporization, excision, incision, and coagulation of soft tissue in general surgery including endoscopic and open procedures. Applications include: Laparoscopic: appendectomy; cholecystectorny; bowel resection. Open: mastectomy; reduction mammoplasty; breast biopsy; rectal and anal hemorrhoidectomy; bowel resection; colectomy; cholecystectomy; liver resection; condyloma; thyroidectorny; thoracotomy; cavernous hemangioma.

    Genitourinary (Urology): The ablation, vaporization, excision, incision, and coagulation of soft tissue in genitourinary (urology) procedures. Applications include: Transurethral: transurethral incision of the prostate (TUIP); bladder tumors; bladder neck incisions; urethral strictures; exterior sphincterotomy. Laparoscopic lymphadenectomy. Open: condyloma; circumcision; benign and malignant lesions of external genitalia

    Thoracic Surgery: The ablation, vaporization, excision, incision, and coagulation of soft tissue in thoracic surgery including endoscopic and open procedures. Applications include: pulmonary resection; coagulation of blebs and bullae; adhesiolysis; pericardiectorny; mediastinal and thoracic lesions and abnormalities; mediastinal lymph node dissection; hemostasis; thoracotomy.

    Gynecology (GYN): The ablation, vaporization, excision, incision, and coagulation of soft tissue in gynecology (GYN) procedures. Applications include: Laparoscopic excision/lysis of adhesions; endometrial lesions, including ablation of endometriosis; laparoscopic assisted hysterectomy (LAVH); laser uterosacral nerve ablation (LUNA); myomectomy; ovarian cystectomy; ovarian drilling; tubal fimbrioplasty; appendectomy. Open: conization of the cervix, including cervical intraepithelial neoplasia (CIN), vulvar and vaginal intraepithelial neoplasia VIN, VAIN; condyloma acuminata, including cervical, genital, vulvar, perineal, and Bowen's disease, (Erythroplasia of Queyrat) and Bowenoid papulosa (BP) lesions. Intrauterine: Fibroids/polyps/adhesions; Resection of septum.

    Pulmonology: The ablation, vaporization, excision, incision, and coagulation of soft tissue in pulmonology procedures. Applications include: tracheal bronchial lesions.

    Ophthalmology: The ablation, vaporization, excision, incision, and coagulation of soft tissue in ophthalmology procedures. Applications include: Oculoplastics; open DCR; endonasal DCR; tumor excision and biopsy; eyelid reconstruction; blepharoplasty.

    Orthopedics: The ablation, vaporization, excision, incision, and coagulation of soft tissue in orthopedic surgery procedures. Applications include: Open: Dissect and coagulate.

    Otolaryngology (ENT): The ablation, vaporization, excision, incision, and coagulation of soft tissue in otolaryngology procedures. Applications include: Nasal/Sinus: turbinectomy and turbinate reduction/ablation; polypectorny of nose and nasal passages; ethmoidectorny; meatal antrostomy; Laryngo-tracheal: removal of vocal cord/fold nodules, polyps and cysts;arytenoidectorny; tracheal stenosis; Oropharyngeal: uvulopalatoplasty (LAUP, laser UTPP); tonsillectorny (including tonsillar cryptolysis, neoplasma) and tonsil; hemi glossectomy; Head & Neck: tumor resection on oral, subfacial and neck tissues; parathyroidectorny; thyroidectorny.

    Podiatry: Podiatry (ablation, vaporization, incision, excision, and coagulation of soft tissue) including: Matrixectomy Periungual and subungual warts, Plantar warts, Neuromas. The Gold Series is indicated for use for the temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes Trichophyton rubrum and T mentagrophytes, and/or yeasts Candida albicans, etc.).

    In addition the Blueshine GOLD series Laser is intended for Laser Assisted Lipolysis

    Device Description

    The GOLD series Laser is designed with 4 major subsystems: (1) an external structure; (2) power electronics; (3) display with control electronics, which controls the power electronics, the user interface and the laser source temperature via a thermostat board; and (4) the laser system with an opto-mechanical block composed of the laser source, the Peltier cooling system with dissipater and fans, the fiber launching system, the red diode aiming beam, and the power calibration system. The external accessories include separate optical fibers and hand pieces for dental, dermatological and surgical applications, or for endovascular applications. The fiber is connected to the system through an SMA 905 socket on the front panel. In addition to the four subsystems, the Diode Laser Family incorporates several safety features, including a remote interlock and a key switch.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study that demonstrates the Blueshine's GOLD series device meets those criteria, based on the provided 510(k) summary:

    1. Table of Acceptance Criteria and Reported Device Performance

    The 510(k) summary does not explicitly state pre-defined acceptance criteria in terms of numerical thresholds for device performance. Instead, it presents the "results" of a clinical study, implying these outcomes are considered acceptable for demonstrating the safety and effectiveness of the device for onychomycosis treatment.

    Criterion (Implicit)Reported Device Performance
    Efficacy in treating Onychomycosis (Overall Improvement)- 93.75% of treated nails improved by at least 1/3 of the nail plate.
    • No nails worsened.
    • 6.25% of nails were unchanged. |
      | Efficacy in treating Onychomycosis (Complete Clearing) | - 77.09% (37 out of 48) of eligible toenails showed complete clear nails (improvement > 2/3).
    • 17% (8 out of 48) showed middle clear (improvement 1/3 to 2/3). |
      | Safety | "The procedure is simple and quick with no noticeable side effects and complications." (This statement acts as the reported safety performance, implying an acceptance criterion of "no noticeable side effects and complications.") |

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size (Test Set): 48 patients with onychomycosis. The study specifically followed 48 treated nails.
    • Data Provenance: The study was conducted in "Two private practices in Padua and Venice, Italy." This indicates the data is prospective (a follow-up study was conducted) and originates from Italy.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts

    The document does not explicitly state the number of experts or their qualifications used to establish the ground truth for the test set. It mentions that "All nails are checked visually and classified," but does not specify who performed this visual check or their credentials.

    4. Adjudication Method for the Test Set

    The document does not describe any specific adjudication method (e.g., 2+1, 3+1). It only states that nails were "checked visually and classified." This suggests a single reviewer or a non-adjudicated consensus, but without more detail, it's impossible to be certain.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No, a multi-reader multi-case (MRMC) comparative effectiveness study was not done. The study described is a single-arm follow-up study on the performance of the Blueshine's GOLD series laser treatment; it does not compare human readers' performance with and without AI assistance, nor does it involve multiple readers.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

    This is not applicable, as the device is a laser surgical instrument, not an AI algorithm. The performance described is the direct clinical outcome of the laser treatment on patients, administered by a human.

    7. Type of Ground Truth Used

    The ground truth used for evaluating the device's efficacy was based on visual assessment and classification of nail improvement.
    The classifications were:

    • Unchanged ( 2/3 improvement)

    This is a clinical expert assessment, but the specific expert qualifications are not detailed.

    8. Sample Size for the Training Set

    This information is not applicable. The device is a medical device (laser instrument), not an AI/machine learning algorithm that requires a "training set" in the computational sense. The "training" for such a device would typically refer to the clinical studies and engineering development that lead to its final design and parameters, rather than a data-driven training set for an algorithm.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable, as there is no "training set" in the context of an AI algorithm. For a physical device, ground truth establishment would refer to the validation of its design and operational parameters through testing and clinical trials, but not in the sense of a machine learning model.

    Ask a Question

    Ask a specific question about this device

    K Number
    K090297
    Manufacturer
    Date Cleared
    2009-04-14

    (67 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Applicant Name (Manufacturer) :

    BLUESHINE SRL

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Blueshine GOLD series , (and the fiber delivery systems and accessories used to deliver laser energy), is indicated for use in surgical applications requiring the ablation, vaporization, excision, incision, and coagulation of soft tissue in medical specialties including: gastroenterology, general surgery, genitourinary surgery (urology), gynecology (GYN), neurosurgery, otolaryngology (ENT), orthopedics, ophthalmology, pulmonology, and thoracic surgery.

    The Blueshine GOLD series Laser is indicated for use in the performance of specific surgical applications in gastroenterology, general surgery, genitourinary surgery (urology), gynecology (GYN), neurosurgery, otolaryngology (ENT), orthopedics, ophthalmology, pulmonology, and thoracic surgery as follows;

    Gastroenterology: The ablation, vaporization, excision, incision, and coagulation of soft tissue in gastroenterology procedures. Applications include: hemostasis of esophageal varices; palliation of malignant dysphagia; palliative ablation of obstructive neoplasms; hemostasis of colonoscopy.

    Neurosurgery: The ablation, vaporization, excision, incision, and coagulation of soft tissue in neurosurgery procedures. Applications include: tumors adjacent to the spinal cord; tumors adjacent to the cortex.

    General Surgery: Treatment of varicose veins and varicosities associated with superficial reflux of the greater saphenous vein. The ablation, vaporization, excision, incision, and coagulation of soft tissue in general surgery including endoscopic and open procedures. Applications include: Laparoscopic: appendectomy; cholecystectomy; bowel resection. Open: mastectomy; reduction mammoplasty; breast biopsy; rectal and anal hemorrhoidectomy; bowel resection; colectomy; cholecystectomy; liver resection; condyloma; thyroidectomy; thoracotomy; cavernous hemangioma.

    Genitourinary (Urology): The ablation, vaporization, excision, incision, and coagulation of soft tissue in genitourinary (urology) procedures. Applications include: Transurethral: transurethral incision of the prostate (TUIP); bladder tumors; bladder neck incisions; urethral strictures; exterior sphincterotomy. Laparoscopic lymphadenectomy. Open: condyloma; circumcision; benign and malignant lesions of external genitalia

    Thoracic Surgery: The ablation, vaporization, excision, incision, and coagulation of soft tissue in thoracic surgery including endoscopic and open procedures. Applications include: pulmonary resection: coagulation of blebs and bullae: adhessiolysis: pericardiectomy; mediastinal and thoracic lesions and abnormalities; mediastinal lymph node dissection; hemostasis; thoracotomy.

    Gynecology (GYN): The ablation, vaporization, excision, incision, and coagulation of soft tissue in gynecology (GYN) procedures. Applications include: Laparoscopic excision/lysis of adhesions; endometrial lesions, including ablation of endometriosis; laparoscopic assisted hysterectomy (LAVH); laser uterosacral nerve ablation (LUNA); myomectomy; ovarian cystectomy; ovarian drilling; tubal fimbrioplasty; appendectomy. Open: conization of the cervix, including cervical intraepithelial neoplasia (CIN), vulvar and vaginal intraepithelial neoplasia VIN, VAIN; condyloma acuminata, including cervical, genital, vulvar, perineal, and Bowen's disease, (Erythroplasia of Queyrat) and Bowenoid papulosa (BP) lesions. Intrauterine: Fibroids/polyps/adhesions; Resection of septum.

    Pulmonology: The ablation, vaporization, excision, incision, and coagulation of soft tissue in pulmonology procedures. Applications include: tracheal bronchial lesions.

    Ophthalmology: The ablation, vaporization, excision, incision, and coagulation of soft tissue in ophthalmology procedures. Applications include: Oculoplastics: open DCR: endo-nasal DCR; tumor excision and biopsv; evelid reconstruction: blepharoplasty.

    Orthopedics: The ablation, vaporization, excision, incision, and coagulation of soft tissue in orthopedic surgery procedures. Applications include: Open: Dissect and coagulate.

    Otolaryngology (ENT): The ablation, vaporization, excision, incision, and coagulation of soft tissue in Cotolaryngology procedures. Applications include: Nasal/Sinus: turbinectomy and turbinate reduction/ablation; polypectomy of nose and nasal passages; ethmoidectomy; meatal antrostomy; Laryngo-tracheal; removal of vocal cord/fold nodules, polyps and cysts;arytenoidectomy; tracheal stenosis; Oropharyngeal: uvulopalatoplasty (LAUP, laser UTPP); tonsillectory (including tonsillar cryptolysis, neoplasma) and tonsil; hemi glossectomy; Head & Neck: tumor resection on oral, subfacial and neck tissues: parathyroidectomy; thyroidectomy.

    In addition the Blueshine GOLD series Laser is intended for Laser Assisted Lipolysis

    Device Description

    Not Found

    AI/ML Overview

    I am sorry, but the provided text from the FDA 510(k) K090297 for the "Blueshine GOLD series Laser System" does not contain information about acceptance criteria or a study proving the device meets those criteria.

    The document primarily focuses on:

    • Substantial Equivalence Determination: The FDA's letter confirming that the device is substantially equivalent to legally marketed predicate devices.
    • Regulatory Information: Details about the device's classification, regulation number, product code, and general controls provisions.
    • Indications for Use: A comprehensive list of medical specialties and specific surgical applications for which the Blueshine GOLD series Laser System is indicated, using 980 nm wavelengths.

    Therefore, I cannot provide the requested table or answer the specific questions about sample sizes, expert qualifications, adjudication methods, MRMC studies, standalone performance, ground truth types, or training set details. This information is typically found in clinical study reports or performance testing sections of a 510(k) submission, which are not present in the provided excerpts.

    Ask a Question

    Ask a specific question about this device

    K Number
    K063060
    Manufacturer
    Date Cleared
    2006-11-29

    (55 days)

    Product Code
    Regulation Number
    878.4810
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    BLUESHINE SRL

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Blueshine Light Shine is intended for permanent hair reduction, photocoagulation of dermatological vascular lesions, photothermolysis of blood vessels (treatment of facial and leg veins), and treatment of benign pigmented lesions and inflammatory acne (acne vulgaris) It can be used for all skin types, from I (subjects with white skin, freckles, blond or red hair, blue or green eyes) to VI (subjects with brown to dark skin/ brown or black hair/ brown eyes included suntanned skin).

    Device Description

    The Blueshine Light Shine System is a pulsed light, wavelength range adjustable system. It provides selectable handpiece aperture sizes for a variety of applications Light emission activation is by foot switch. Overall weight of the system is 110lbs., and the size is 57x56x98cm (LxWxH). Electrical requirement is 110 VAC, 16A, 50-60 Hz, single phase.

    AI/ML Overview

    The provided 510(k) summary for the Blueshine Light Shine system indicates that no clinical performance data or nonclinical performance data were submitted to demonstrate the device meets acceptance criteria.

    The submission relies on a claim of "substantial equivalence" to predicate devices (Radiancy (Israel) Ltd Skinstation system, K030897, and Sciton, Inc. Profile BBL system, K032460) based on similar indications for use, principle of operation, wavelength range, and pulse energy range.

    Therefore, the requested information regarding acceptance criteria and a study proving the device meets those criteria cannot be extracted from this document, as such information was not provided in the 510(k) submission.

    Summary of unavailable information:

    1. Table of acceptance criteria and reported device performance: Not provided. The submission states "Nonclinical Performance Data: None" and "Clinical Performance Data: None."
    2. Sample size used for the test set and data provenance: Not applicable as no performance studies were submitted.
    3. Number of experts used to establish the ground truth for the test set and their qualifications: Not applicable.
    4. Adjudication method for the test set: Not applicable.
    5. Multi-Reader Multi-Case (MRMC) comparative effectiveness study: Not done/reported.
    6. Standalone (algorithm only) performance study: Not applicable as this is a physical device, and no algorithm-only performance was assessed.
    7. Type of ground truth used: Not applicable.
    8. Sample size for the training set: Not applicable as no studies involving training sets were reported.
    9. How the ground truth for the training set was established: Not applicable.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1